SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Net Income for Purposes of Determining Basic and Diluted EPS Applicable to Common Shares

Net income for purposes of determining basic and diluted EPS applicable to common shares was as follows:

	Three Months Ended
	March 31,
	2024		2023
Net income	$	34,800	$	34,741
Income attributable to participating securities	(882)		(930)
Net income available to common stockholders	$	33,918	$	33,811

Schedule of Basic and Diluted EPS

Basic and diluted EPS were calculated using the following common shares:

	Three Months Ended
	March 31,
	2024	2023
Weighted-average shares for basic EPS	153,451,264	153,012,937
Incremental shares related to stock options and non-vested restricted stock	193,015	147,499
Weighted-average shares for diluted EPS	153,644,279	153,160,436

Schedule of Computation of Diluted EPS Expense Associated With Non-vested Restricted Stock of the Common Shares

The following non-vested restricted stock was outstanding during the three months ended March 31, 2024 and 2023, respectively, and was not included in the computation of diluted EPS because the impact of the per share expense associated

with the non-vested restricted stock was greater than the average market price of the common shares during the respective periods.

	Three Months Ended
	March 31,
	2024		2023
Weighted-average shares of non-vested restricted stock	9,011		366,667
Weighted-average expense per share	$	12.90	$	12.90

Schedule of Other, Net

Other, net consisted of:

	Three Months Ended
	March 31,
	2024		2023
Interest and dividend income	$	5,459	$	3,935
Net gains (losses) recognized on investment securities	1,196		(6)
Net periodic benefit cost other than the service costs	(268)		(339)
Other income	(2)		30
Other, net	$	6,385	$	3,620

Schedule of Other Assets

Other assets consisted of:

	March 31, 2024		December 31, 2023
Restricted assets	$	978	$	1,619
Prepaid pension costs	46,008		45,292
Other assets	38,393		37,418
Total other assets	$	85,379	$	84,329

Schedule of Other Current Liabilities

Other current liabilities consisted of:

	March 31, 2024		December 31, 2023
Accounts payable	$	12,286	$	6,749
Accrued promotional expenses	47,210		51,146
Accrued excise and payroll taxes payable, net	15,545		13,144
Accrued interest	31,078		30,041
Accrued salaries and benefits	4,341		10,952
Allowance for sales returns	12,943		12,675
Other current liabilities	11,170		6,973
Total other current liabilities	$	134,573	$	131,680

Schedule of Cash and Cash Equivalents

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	March 31, 2024		December 31, 2023
Cash and cash equivalents	$	332,593	$	268,600
Restricted cash and cash equivalents included in other assets	866		1,506
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	333,459	$	270,106

Schedule of Restricted Cash

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	March 31, 2024		December 31, 2023
Cash and cash equivalents	$	332,593	$	268,600
Restricted cash and cash equivalents included in other assets	866		1,506
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	333,459	$	270,106